Senestech Inc

Senestech Inc(SNES)股票分析

$0.647

-0.048 (-7.48%)收盘时

Loading chart…
最高
0.720
开盘
0.642
成交量加权均价
0.64
成交量
1.27M
市值
2.94M
最低
0.550
成交额
812.64K
企业价值/息税折旧摊销前利润(TTM)
-0.11

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

AI 分析 of Senestech Inc (SNES)

持有

Senestech Inc shows potential for future growth, but current indicators suggest it may not be a good buy right now. The stock has a current price of $0.65, with a 1-year change of -83.99%, indicating significant decline. The RSI is at 38.654, suggesting it is nearing oversold territory, but the forward P/E ratio of 3.399 indicates potential undervaluation. However, the risk remains high due to a net income loss of $2.06 million in Q1 2026 and a YTD change of -70.73%.

分析师评级(2)

上行空间 +1445.83%
买入
2 买入
0 持有
0 卖出
当前: 0.65
最低
10.00
平均
10.00
最高
10.00

HC Wainwright & Co.

2024-12-13

目标价

$10

强烈买入

HC Wainwright & Co.

2024-12-12

目标价

$10

强烈买入

HC Wainwright & Co.

2024-05-14

目标价

$3.5

强烈买入

HC Wainwright & Co.

2023-12-28

目标价

$3.5

强烈买入

HC Wainwright & Co.

2023-05-24

目标价

$48

强烈买入

估值指标

Senestech Inc(SNES)当前预期市盈率为 3.40,5 年平均预期市盈率为 -0.42。

预期市盈率

严重高估
5 年均值 P/E
-0.42
当前P/E
3.40
高估
1.12
低估
-1.96

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-0.45
当前EV/EBITDA
-0.11
高估
0.60
低估
-1.49

预期市销率

合理
5 年均值 P/S
2.33
当前P/S
0.83
高估
4.69
低估
-0.02

Alphio AI 对 SNES 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%SNES

$3.91

情景价格

基

基准

基准 · 50%SNES

$3.75

情景价格

悲

悲观

悲观 · 25%SNES

$3.33

情景价格

事件时间线

2026-10-15 (ET)

08:30:00

SenesTech Achieves First $1M Revenue in Q3

2026-09-23 (ET)

09:00:00

SenesTech Launches Evolve Products on Grove Collaborative

2026-08-31 (ET)

09:00:00

SenesTech Reduces Rodent Activity by 43% in Massachusetts

2026-08-03 (ET)

09:00:00

SenesTech's Online Subscription Customers More Than Doubled

2026-07-09 (ET)

09:01:00

SenesTech Successfully Implements Evolve Rodent Control in Texas

资讯

SNES 常见问题 —— 由 Alphio AI 解答

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption. It operates in the Basic Materials sector (AGRICULTURAL CHEMICALS industry).

Senestech Inc shows potential for future growth, but current indicators suggest it may not be a good buy right now. The stock has a current price of $0.65, with a 1-year change of -83.99%, indicating significant decline. The RSI is at 38.654, suggesting it is nearing oversold territory, but the forward P/E ratio of 3.399 indicates potential undervaluation. However, the risk remains high due to a net income loss of $2.06 million in Q1 2026 and a YTD change of -70.73%.

2 analysts cover SNES: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易